Telcagepant provides new hope for people with migraine

Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

Abstract

The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Neurologi
Originalspråkengelska
Sidor (från-till)240-242
TidskriftNature Reviews Neurology
Volym5
Utgivningsnummer5
StatusPublished - 2009
PublikationskategoriForskning
Peer review utfördNej